I’ve been asking Diabetes UK to build the economic business case for pumps for some time – the pump companies have the data because they need it to get their products approved (I asked Medtronic about it when we were in Lausanne) but I haven’t been able to get them interested so far.
That said, I don’t think this is a case of not having the evidence, I think its more that they have to cut costs and this seems an easy route. NHS finances are generally run on a 3yr budget, so savings over 10yrs don’t really interest them. In which case I’d stick to the basics – the guidelines say X, you’re not delivering against them, and argue from there. But I seem to remember you Scottish types don’t abide by the NICE guidelines as much as we do in England – are there any guidelines that they’re meant to deliver against and do they include pump provision as a standard?